Zdrenghea Mihnea T, Makrinioti Heidi, Muresan Adriana, Johnston Sebastian L, Stanciu Luminita A
Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania; Iuliu Hatieganu, University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Rev Med Virol. 2015 Jan;25(1):33-49. doi: 10.1002/rmv.1817. Epub 2014 Nov 27.
Activation through different signaling pathways results in two functionally different types of macrophages, the pro-inflammatory (M1) and the anti-inflammatory (M2). The polarization of macrophages toward the pro-inflammatory M1 phenotype is considered to be critical for efficient antiviral immune responses in the lung. Among the various cell types that are present in the asthmatic airways, macrophages have emerged as significant participants in disease pathogenesis, because of their activation during both the inflammatory and resolution phases, with an impact on disease progression. Polarized M1 and M2 macrophages are able to reversibly undergo functional redifferentiation into anti-inflammatory or pro-inflammatory macrophages, respectively, and therefore, macrophages mediate both processes. Recent studies have indicated a predominance of M2 macrophages in asthmatic airways. During a virus infection, it is likely that M2 macrophages would secrete higher amounts of the suppressor cytokine IL-10, and less innate IFNs. However, the interactions between IL-10 and innate IFNs during virus-induced exacerbations of asthma have not been well studied. The possible role of IL-10 as a therapy in allergic asthma has already been suggested, but the divergent roles of this suppressor molecule in the antiviral immune response raise concerns. This review attempts to shed light on macrophage IL-10-IFNs interactions and discusses the role of IL-10 in virus-induced asthma exacerbations. Whereas IL-10 is important in terminating pro-inflammatory and antiviral immune responses, the presence of this immune regulatory cytokine at the beginning of virus infection could impair the response to viruses and play a role in virus-induced asthma exacerbations.
通过不同信号通路激活会产生两种功能不同的巨噬细胞类型,即促炎性(M1)巨噬细胞和抗炎性(M2)巨噬细胞。巨噬细胞向促炎性M1表型的极化被认为对肺部有效的抗病毒免疫反应至关重要。在哮喘气道中存在的各种细胞类型中,巨噬细胞已成为疾病发病机制中的重要参与者,因为它们在炎症期和消退期均被激活,从而影响疾病进展。极化的M1和M2巨噬细胞能够分别可逆地重新分化为抗炎性或促炎性巨噬细胞,因此,巨噬细胞介导这两个过程。最近的研究表明哮喘气道中M2巨噬细胞占优势。在病毒感染期间,M2巨噬细胞可能会分泌更高量的抑制性细胞因子白细胞介素-10(IL-10),而先天性干扰素分泌较少。然而,在病毒诱发的哮喘加重过程中,IL-10与先天性干扰素之间的相互作用尚未得到充分研究。IL-10作为过敏性哮喘治疗方法的潜在作用已经被提出,但这种抑制分子在抗病毒免疫反应中的不同作用引发了人们的担忧。本综述试图阐明巨噬细胞IL-10-干扰素之间的相互作用,并讨论IL-10在病毒诱发的哮喘加重中的作用。虽然IL-10在终止促炎性和抗病毒免疫反应中很重要,但在病毒感染开始时这种免疫调节细胞因子的存在可能会损害对病毒的反应,并在病毒诱发的哮喘加重中起作用。